Skip to main content
SHIELD THERAPEUTICS PLC logo

SHIELD THERAPEUTICS PLC — Investor Relations & Filings

Ticker · STX ISIN · GB00BYV81293 LEI · 213800G74QWY15FC3W71 IL Manufacturing
Open in API
Filings indexed 408 across all filing types
Latest filing 2020-05-28 Regulatory Filings
Country GB United Kingdom
Listing IL STX

About SHIELD THERAPEUTICS PLC

https://www.shieldtherapeutics.com/

Shield Therapeutics is a commercial-stage specialty pharmaceutical company focused on addressing iron deficiency. The company's mission is to improve the lives of patients suffering from this condition, with or without anemia. Its lead product is Accrufer® (ferric maltol), also marketed as Feraccru®, a novel, stable, non-salt-based oral therapy. This innovative pharmaceutical is broadly indicated for use in adults across multiple therapeutic categories, aiming to provide an effective and well-tolerated treatment for a significant unmet medical need.

Recent filings

Filing Released Lang Actions
Investor presentations
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and the closing statement referencing 'RNS, the news service of the London Stock Exchange'. The content explicitly announces that the company will be 'presenting at two investor presentations next month' and provides details for attending these webinars. This is an announcement about future investor engagement, specifically presentations, rather than the release of a formal financial report (like 10-K or IR) or the presentation material itself. Since the core purpose is to inform investors about upcoming presentations, the most fitting category is 'Investor Presentation' (IP). Although it is distributed via RNS, the specific content points directly to IP.
2020-05-28 English
Appointment of Chairman
Board/Management Information Classification · 99% confidence The document starts with an 'RNS Number' and is dated May 26, 2020. The core content announces the 'Appointment of Chairman' (Hans Peter Hasler) effective from the upcoming Annual General Meeting (AGM). This is a specific announcement regarding a change in senior management/board composition. This directly matches the definition for Board/Management Information (MANG). Although it mentions the AGM, the primary focus is the management change, not the AGM materials themselves (AGM-R) or the voting results (DVA). It is not a general regulatory filing (RNS) because it fits a more specific category.
2020-05-26 English
Annual Report and Accounts 2019
Annual Report Classification · 100% confidence The document is explicitly titled 'Annual report and accounts 2019' for Shield Therapeutics plc. It contains a comprehensive structure including a strategic report, corporate governance, financial statements, and independent auditor's report. It covers the full fiscal year 2019 and provides detailed financial data, management commentary, and operational highlights. It meets all criteria for an Annual Report (10-K equivalent for UK-listed companies). FY 2019
2020-05-22 English
2019 Annual Report and 2020 AGM Notice
Report Publication Announcement Classification · 99% confidence The document is an RNS (Regulatory News Service) announcement from Shield Therapeutics PLC, dated May 22, 2020. The primary purpose of the announcement is to inform shareholders that two documents have been sent: the '2019 Annual Report and Accounts' and the 'Notice of Annual General Meeting ("AGM") 2020'. Since the document itself is a short announcement stating that reports have been published and sent to shareholders, and it is distributed via RNS, it fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given the explicit mention of the AGM Notice and the Annual Report being sent out, RPA is highly relevant, but RNS is the general regulatory distribution channel used here. Since the content is primarily about the publication/distribution of other documents (Annual Report and AGM Notice), RPA is the most specific fit among the publication-related codes, although RNS is also applicable as the distribution mechanism. However, the document explicitly mentions the AGM Notice, which points towards AGM-R materials being involved, but this document is the *announcement* of those materials. Given the structure (RNS Number, announcement of documents sent, details about the upcoming AGM), RPA (Report Publication Announcement) is the best fit for the act of announcing the availability of the Annual Report and AGM Notice, rather than being the report itself (10-K or AGM-R). I will select RPA as it describes the action taken by the company regarding the reports.
2020-05-22 English
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1380 characters) and begins with 'RNS Number : 6740N', indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Second Price Monitoring Extension' for a security, which is a specific operational notice related to trading halts or volatility controls. This type of miscellaneous, non-standard regulatory announcement that doesn't fit into specific categories like earnings, director dealings, or capital changes is best classified under the general regulatory filing category, RNS (Regulatory Filings), as per the provided definitions and the 'MENU VS MEAL' rule (it's an announcement, not a full report).
2020-05-21 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1363 characters) and begins with 'RNS Number : 6720N', indicating it is a regulatory news service announcement from the London Stock Exchange. The content describes a 'Price Monitoring Extension' related to trading mechanics, which is a general regulatory update rather than a specific financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement that doesn't fit the specific categories like DIRS, DIV, or MANG, the most appropriate fallback category is Regulatory Filings (RNS).
2020-05-21 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.